Muhrat Al Marasim
Official Circulars & Regulatory Notices

Regulatory newsroom.

الأخبار والتعاميم التنظيمية الرسمية

Stay abreast of the latest Saudi Food and Drug Authority circulars, GCC health council directives, and international compliance announcements.

SFDA CircularSeptember 2025 • Circular No. MDS-CIR-2025-09

SFDA Publishes Updated Guidelines for Unique Device Identification (UDI) Phase 3 Enforcement

The Saudi Food and Drug Authority mandates full GS1 barcoding integration for all Class IIa medical devices entering Saudi ports, effective January 2026.

Actionable Industry Impact: Foreign manufacturers must index their DI barcodes in the Saudi DI Database prior to customs shipment generation.
GCC HarmonizationAugust 2025 • GCC Health Council Bulletin #44

GCC Health Council Expands Mutual Recognition for Fast-Track Priority Review Applications

New expedited multi-market clearance protocols allow parallel filing across Saudi Arabia, UAE, and Oman with unified technical documentation.

Actionable Industry Impact: Approved CE MDR dossiers can leverage mutual recognition to reduce GCC review cycles by up to 50 days.
Corporate EventsJuly 2025 • Press Release

Muhrat Al Marasim Concludes ISO 13485:2016 Lead Auditor Regulatory Forum in Riyadh

Over 120 biomedical executives and hospital procurement directors gathered to review emerging compliance directives under Vision 2030.

Actionable Industry Impact: Participants reviewed cold-chain temperature mapping SOPs and SFDA Medical Device Establishment License (MDEL) audit protocols.
Digital HealthJune 2025 • MDS-G015 Addendum

SFDA Medical Device Sector Issues Guidance on Clinical AI and SaMD Post-Market Vigilance

New statutory requirements governing continuous performance monitoring and cybersecurity patch reporting for clinical algorithms deployed in the Kingdom.

Actionable Industry Impact: Software manufacturers must appoint a local vigilance officer with 24/7 incident reporting capabilities.